The White House is set to announce drug pricing deals with pharmaceutical heavyweights Novartis AG and Roche Holding AG as soon as Friday, according to people familiar with the situation, further easing trade tensions with Switzerland after a standoff over tariffs.
Other drugmakers could also be included in the announcement, and the details remain in flux, the people said. Pfizer Inc., AstraZeneca Plc and other companies have struck deals with the Trump administration in recent months, agreeing to lower prices in certain instances in return for relief from tariffs.
Shares of both Roche and Novartis slipped about 0.7% in ...
